Anti-obesity medications: Wegovy and Mounjaro set to be reimbursed
Anti-obesity medications Wegovy and Mounjaro are set to be reimbursed by France's health insurance.
Published 17sem·2 sources✓ ConfirmedNotable·updated 6sem
The fact
This decision aims to improve access to these treatments for patients suffering from obesity and its health complications.
Reimbursement represents a major advance in the therapeutic management of obesity in France.
🔗2 sources — click a link to read an article on the topic:
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→Story timeline
May 28Anti-obesity medications: Wegovy and Mounjaro set to be reimbursedthis article